Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Completed3

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT04875520Not ApplicableCompleted
Assessing Testing Strategies for Safe Return to K-12 Schools in an Underserved Population
Covid19
PrincipalinvestigatorStart date: 2021-05-07
NCT04565509Not ApplicableCompleted
Supporting the Health and Well-being of Children With Intellectual and Developmental Disability During COVID-19 Pandemic
Child Development DisorderCovid19Developmental Disability+1 more
PrincipalinvestigatorStart date: 2020-11-20
NCT03037112Not ApplicableCompleted
Resetting the Default: Improving Provider-patient Communication to Reduce Antibiotic Misuse
Anti-Bacterial AgentsCommunicationDecision Making+1 more
PrincipalinvestigatorStart date: 2017-03-03

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Kathy Goggin, PhD

Childrens Mercy Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Anti-Bacterial AgentsCommunicationDecision Making+1 more

Worked with same sponsors:

Children's Mercy Hospital Kansas CityHeartland Primary Care of Sunflower Medical Group+2 more
Collaborated on 1 trial
Similarity Score44%

Xiaolong Qi, MD

LanZhou University

Related
8 trials

Shared therapeutic areas:

COVID-19
Similarity Score4%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

COVID-19
Similarity Score4%

Toshimitsu Tokimoto

Astrazeneca KK

Related
16 trials

Shared therapeutic areas:

COVID-19
Similarity Score4%

Mohamed mamdouh Elsayed, MD

Lecturer

Related
11 trials

Shared therapeutic areas:

COVID-19
Similarity Score4%

Jack A Yanovski, M.D.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Related
23 trials

Shared therapeutic areas:

Intellectual Disability

Worked with same sponsors:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Similarity Score4%

Melissa Stockwell, MD MPH

Columbia University

Related
14 trials

Shared therapeutic areas:

COVID-19
Similarity Score4%

Matthew J Memoli, M.D.

National Institute of Allergy and Infectious Diseases (NIAID)

Related
15 trials

Shared therapeutic areas:

COVID-19
Similarity Score4%

Grace E Parraga, PhD

Robarts Research Institute, The University of Western Ontario

Related
16 trials

Shared therapeutic areas:

COVID-19
Similarity Score4%

Meral Boşnak Güçlü, Prof. Dr.

Gazi University

Related
22 trials

Shared therapeutic areas:

COVID-19
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT04875520Not ApplicablePrincipalInvestigator

Assessing Testing Strategies for Safe Return to K-12 Schools in an Underserved Population

Covid19
Completed
NCT04565509Not ApplicablePrincipalInvestigator

Supporting the Health and Well-being of Children With Intellectual and Developmental Disability During COVID-19 Pandemic

Child Development DisorderCovid19Developmental Disability+1 more
Completed
NCT03037112Not ApplicablePrincipalInvestigator

Resetting the Default: Improving Provider-patient Communication to Reduce Antibiotic Misuse

Anti-Bacterial AgentsCommunicationDecision Making+1 more
Completed

All 3 trials loaded